Oxidative stress-induced death in the nervous system: Cell cycle dependent or independent?

Journal of Neuroscience Research

Volumn 77, Issue 5, 2004, Pages 621-629

  Langley, Brett ^a   Ratan, Rajiv R ^a,b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Cell cycle; Cyclin dependent kinase (Cdk); Neuron(s); Oxidative stress

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; HUMAN; MITOSIS; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; GENE EXPRESSION REGULATION; HUMANS; MODELS, NEUROLOGICAL; NERVOUS SYSTEM; NEURONS; OXIDATIVE STRESS;

EID: 4444277253     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20210     Document Type: Short Survey

References (119)

1. Ames BN, Shigenaga MK. 1992. Oxidants are a major contributor to aging. Ann N Y Acad Sci 663:85-96.
2. Baek BS, Kwon HJ, Lee KH, Yoo MA, Kim KW, Ikeno Y, Yu BP, Chung HY. 1999. Regional difference of ROS generation, lipid peroxidation, and antioxidant enzyme activity in rat brain and their dietary modulation. Arch Pharmacol Res 22:361-366.
3. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. 1993. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 52:659-666.
4. Bazan NG. 2003. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 44:2221-2233.
5. Beal MF. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
6. Beal MF. 2003. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci 991:120-131.
7. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 87:1620-1624.
8. Bell LA, Ryan KM. 2004. Life and death decisions by E2F-1. Cell Death Differ 11:137-142.
9. Blomberg I, Hoffmann I. 1999. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol 19:6183-6194.
10. Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF. 2001. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J Neurochem 79:1246-1249.
11. Bonini P, Cicconi S, Cardinale A, Vitale C, Serafino AL, Ciotti MT, Marlier LN. 2004. Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die. J Neurosci Res 75:83-95.
12. Bonni A. 2003. Neurodegeneration: A non-apoptotic role for AIF in the brain. Curr Biol 13:R19-R21.
13. Browne SE, Ferrante RJ, Beal MF. 1999. Oxidative stress in Huntington's disease. Brain Pathol 9:147-163.
14. Butterfield DA, Drake J, Pocernich C, Castegna A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7:548-554.
15. Cafe C, Torri C, Bertorelli L, Tartara F, Tancioni F, Gaetani P, Rodriguez y Baena R, Marzatico F. 1995. Oxidative events in neuronal and glial cell-enriched fractions of rat cerebral cortex. Free Radic Biol Med 19:853-857.
16. Cain K, Bratton SB, Cohen GM. 2002. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84:203-214.
17. Cardoso SM, Pereira C, Oliveira CR. 1998. The protective effect of vitamin E, idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochem Biophys Res Commun 246:703-710.
18. Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G. 2003. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61:365-374.
19. Castedo M, Perfettini JL, Roumier T, Kroemer G. 2002. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 9:1287-1293.
20. Chance B, Sies H, Boveris A. 1979. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605.
21. Chen H, Tappel AL. 1995. Vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, beta-carotene, canthaxanthin, and (+)-catechin protect against oxidative damage to kidney, heart, lung and spleen. Free Radic Res 22:177-186.
22. Conway KA, Rochet JC, Bieganski RM, Lansbury PT, Jr. 2001. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346-1349.
23. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. 1996. Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445.
24. De Souza CP, Ellem KA, Gabrielli BG. 2000. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp Cell Res 257:11-21.
25. Debbas M, White E. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546-554.
26. Dell KR, Turck CW, Vale RD. 2000. Mitotic phosphorylation of the dynein light intermediate chain is mediated by cdc2 kinase. Traffic 1:38-44.
27. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, Faden AI. 2003. Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 53:454-468.
28. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP, Choi DW. 1995. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377-6388.
29. Ekholm SV, Reed SI. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12:676-684.
30. Ewen ME. 2000. Where the cell cycle and histones meet. Genes Dev 14:2265-2270.
31. Flint DH, Tuminello JF, Emptage MH. 1993. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 268:22369-22376.
32. Floyd RA. 1990. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587-2597.
33. Galan A, Garcia-Bermejo L, Troyano A, Vilaboa NE, Fernandez C, de Blas E, Aller P. 2001. The role of intracellular oxidation in death induction (apoptosis and necrosis) in human promonocytic cells treated with stress inducers (cadmium, heat, X-rays). Eur J Cell Biol 80:312-320.
34. Grana X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383.
35. Gross A, McDonnell JM, Korsmeyer SJ. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
36. Guegan C, Levy V, David JP, Ajchenbaum-Cymbalista F, Sola B. 1997. c-Jun and cyclin D1 proteins as mediators of neuronal death after a focal ischaemic insult. Neuroreport 8:1003-1007.
37. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623.
38. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E. 1996. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10:461-477.
39. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. 1999. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98:859-869.
40. Harvey KJ, Lukovic D, Ucker DS. 2000. Caspase-dependent Cdk activity is a requisite effector of apoptotic death events. J Cell Biol 148:59-72.
41. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. 1999. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10:717-721.
42. Heintz N. 1993. Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem Sci 18:157-159.
43. Ishige K, Schubert D, Sagara Y. 2001. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433-446.
44. Jenner P. 2003. Oxidative stress in Parkinson's disease. Ann Neurol 53(Suppl 3):S26-S36 [discussion S36-S38].
45. Jinno S, Hung SC, Okayama H. 1999. Cell cycle start from quiescence controlled by tyrosine phosphorylation of Cdk4. Oncogene 18:565-571.
46. Katchanov J, Harms C, Gertz K, Hauck L, Waeber C, Hirt L, Priller J, von Harsdorf R, Bruck W, Hortnagl H, Dirnagl U, Bhide PG, Endres M. 2001. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci 21:5045-5053.
47. Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
48. Kim SJ, Kim TS, Hong S, Rhim H, Kim IY, Kang S. 2003. Oxidative stimuli affect polyglutamine aggregation and cell death in human mutant ataxin-1-expressing cells. Neurosci Lett 348:21-24.
49. Kitamura Y, Ota T, Matsuoka Y, Tooyama I, Kimura H, Shimohama S, Nomura Y, Gebicke-Haerter PJ, Taniguchi T. 1999. Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells. Glia 25:154-164.
50. Klein JA, Ackerman SL. 2003. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111:785-793.
51. Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, Bronson RT, Ackerman SL. 2002. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419:367-374.
52. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH. 2001. p35 And p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771.
53. Konishi Y, Lehtinen M, Donovan N, Bonni A. 2002. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell 9:1005-1016.
54. Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, Pines J, Peters JM. 2003. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J 22:6598-6609.
55. Kumar S, Bharti A, Mishra NC, Rama D, Kharbanda S, Saxena S, Kufe D. 2001. Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to Oxidative stress. J Biol Chem 276:17281-17285.
56. Lass A, Agarwal S, Sohal RS. 1997. Mitochondrial ubiquinone homologues, Superoxide radical generation, and longevity in different mammalian species. J Biol Chem 272:19199-19204.
57. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, Matzuk MM. 1996. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93:9782-9787.
58. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
59. Lee SS, Kim YM, Junn E, Lee G, Park KH, Tanaka M, Ronchetti RD, Quezado MM, Mouradian MM. 2003. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol Aging 24:687-696.
60. Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, Roberts JM, Ross R. 1998. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1:553-563.
61. Li Y, Chopp M, Powers C. 1997a. Granule cell apoptosis and protein expression in hippocampal dentate gyrus after forebrain ischemia in the rat. J Neurol Sci 150:93-102.
62. Li Y, Chopp M, Powers C, Jiang N. 1997b. Immunoreactivity of cyclin D1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat. J Cereb Blood Flow Metab 17:846-856.
63. Liu DX, Greene LA. 2001a. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res 305:217-228.
64. Liu DX, Greene LA. 2001b. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32:425-438.
65. Luo Y, Umegaki H, Wang X, Abe R, Roth GS. 1998. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 273:3756-3764.
66. Mahadik SP, Scheffer RE. 1996. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:45-54.
67. Martindale JL, Holbrook NJ. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15.
68. Mate MJ, Ortiz-Lombardia M, Boitel B, Haouz A, Tello D, Susin SA, Penninger J, Kroenier G, Alzari PM. 2002. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 9:442-446.
69. Mattson MP. 2000. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120-129.
70. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. 1997. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150:1933-1939.
71. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC. 1998. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 18:159-163.
72. Meplan C, Richard MJ, Hainaut P. 2000. Redox signalling and transition metals in the control of the p53 pathway. Biochem Pharmacol 59:25-33.
73. Miake-Lye R, Kirschner MW. 1985. Induction of early mitotic events in a cell-free system. Cell 41:165-175.
74. Miyagi K, Kawakami K, Saito A. 1997. Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun 65:4108-4113.
75. Mo JQ, Hom DG, Andersen JK. 1995. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech Ageing Dev 81:73-82.
76. Nagy Z, Esiri MM, Cato AM, Smith AD. 1997. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 94:6-15.
77. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, Zhang MQ, Lazebnik Y, Bar-Sagi D, Lowe SW. 2002. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4:859-864.
78. Nicotera P, Leist M, Ferrando-May E. 1999. Apoptosis and necrosis: different execution of the same death. Biochem Soc Symp 66:69-73.
79. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93:11173-11178.
80. Ohtsubo M, Roberts JM. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
81. Park DS, Farinelli SE, Greene LA. 1996. Inhibitors of cyclin-dependent kinases promote survival of post mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Biol Chem 271:8161-8169.
82. Park DS, Morris EJ, Greene LA, Geller HM. 1997. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci 17:1256-1270.
83. Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA. 1998a. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 143:457-467.
84. Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, Greene LA. 1998b. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 18:830-840.
85. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622.
86. Patzke H, Tsai LH. 2002. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem 277:8054-8060.
87. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA. 1999. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411-2415.
88. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH. 1996. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335-1341.
89. Ratan RR, Murphy TH, Baraban JM. 1994. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 62:376-379.
90. Reed SI. 1997. Control of the G1/S transition. Cancer Surv 29:7-23.
91. Reiter CD, Teng RJ, Beckman JS. 2000. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 275:32460-32466.
92. Resnitzky D, Gossen M, Bujard H, Reed SI. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679.
93. Retz W, Gsell W, Munch G, Rosler M, Riederer P. 1998. Free radicals in Alzheimer's disease. J Neural Transm Suppl 54:221-236.
94. Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H, Namura S. 2000. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett 288:163-166.
95. Schwartzman RA, Cidlowski JA. 1993. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151.
96. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
97. Smits VA, Medema RH. 2001. Checking out the G(2)/M transition. Biochim Biophys Acta 1519:1-12.
98. Squier TC. 2001. Oxidative stress and protein aggregation during biological aging. Exp Gerontol 36:1539-1550.
99. Stanciu M, DeFranco DB. 2002. Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J Biol Chem 277:4010-4017.
100. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, DeFranco DB. 2000. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275:12200-12206.
101. Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336.
102. Sun X, Majumder P, Shioya H, Wu F, Kumar S, Weichselbaum R, Kharbanda S, Kufe D. 2000a. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275:17237-17240.
103. Sun X, Wu F, Datta R, Kharbanda S, Kufe D. 2000b. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 275:7470-7473.
104. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446.
105. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH. 1995. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 270:26897-26903.
106. Tinisit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, Khrestchatisky M. 1999. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci 11:263-278.
107. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E. 1994. p35 Is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423.
108. Vermeulen K, Berneman ZN, Van Bockstaele DR. 2003. Cell cycle and apoptosis. Cell Prolif 36:165-175.
109. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K. 1999. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 19:6379-6395.
110. Vincent I, Jicha G, Rosado M, Dickson DW. 1997. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17:3588-3598.
111. Wartiovaara K, Barnabe-Heider F, Miller FD, Kaplan DR. 2002. N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J Neurosci 22:815-824.
112. Watters DJ. 2003. Oxidative stress in ataxia telangiectasia. Redox Rep 8:23-29.
113. Weishaupt JH, Neusch C, Bahr M. 2003. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res 312:1-8.
114. Xiong Y, Zhang H, Beach D. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
115. Yamashiro S, Yamakita Y, Hosoya H, Matsumura F. 1991. Phosphorylation of non-muscle caldesmon by p34cdc2 kinase during mitosis. Nature 349:169-172.
116. Yang A, McKeon F. 2000. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199-207.
117. Zhang Y, Xiong Y, Yarbrough WG. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.
118. Zhou BB, Li H, Yuan J, Kirschner MW. 1998. Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc Natl Acad Sci U S A 95:6785-6790.
119. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G. 2004. Oxidative stress signalling in Alzheimer's disease. Brain Res 1000:32-39.